CompaniesPhost'in Therapeutics
Phost'in Therapeutics logo

Phost'in Therapeutics

active
Montpellier, France
Founded 2012
Website
About

Therapies Targeting Cancer Stem Cell Proliferation

Areas of Focus

Categories

Small Molecule Pharmaceutical
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

149

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT05495295
Hover over trial bars to see details

Recent Trials

NCT05495295Lead Sponsor
First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours
PHASE1Recruiting
149 participants
Started: Jul 18, 2022 · Completed: Jul 31, 2027
Locations (1)
Headquarters
Montpellier, France
Map

Loading map...